· Intro: prostaglandins
· Pathway
· Smooth muscle effects
Definition |
· Lipid mediators derived from arachidonic acid · Production induced by cyclo-oxygenase o COX-1: constitutive, for homeostasis o COX-2: inducible, for inflammation etc |
Actions |
· Autocrine and/or paracrine · Inhibitory or excitatory · Two PGs may have opposing effects at the same tissue o e.g. TXA2 vasoconstriction, PGI2 vasodilation · One PG may have different effects on different tissues o e.g. PGI2 vasodilation, GIT smooth muscle constriction |
Cellular mechanism |
· Bind to G protein coupled receptors o Gs : ↑cAMP o Gi : ↓cAMP o Gq : ↑IP3/DAG -> ↑Ca2+ |
Systemic vascular |
· PGI2 vasodilatation (e.g. by vascular endothelium), promotes rapid laminar flow · TXA2 vasoconstriction (e.g. ↑release by platelet in tissue injury), assists haemostasis (low dose aspirin: ↓TXA2 but ↔PGI2 -> ↓risk AMI) |
Pulmonary vascular |
· PGD2 -> ↓HPV · (Leukotrienes -> ↑HPV) |
Renovascular |
· Contributes to hormonal autoregulation of GFR, i.e. renin-angiotensin system · ↓NaCl to macula densa -> ↑PGE2, PGI2 release -> ↑renin release · (NSAID -> risk of renal impairment, fluid retention) |
Airway |
· PGD2, PGF2α -> bronchoconstriction · PGE2 -> bronchodilatation (corticosteroids -> ↓airway reactivity in asthma) |
Uterine |
· PGE2, PGF2α -> myometrial contraction · Important in menstruation, labour · Receptors always present cf. oxytocin receptors upregulated at 36/40 (misoprostol and exogenous PGF2α reduce risk of PPH) |
Ureteric |
· PGE2 -> relax · PGF2α -> contract (NSAID useful in renal colic) |
Feedback welcome at ketaminenightmares@gmail.com